For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
9
views
10
references
 Top references
cited by
0
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
1 collections
    0
    shares
      222
      similar
       All similar

      Therapeutics and Clinical Risk Management (submit here)

      This international, peer-reviewed Open Access journal by Dove Medical Press focuses on reporting of clinical studies, outcomes and safety in all therapeutic areas and surgical intervention areas. Sign up for email alerts here.

      34,006 Monthly downloads/views I 2.755 Impact Factor I 4.5 CiteScore I 1.0 Source Normalized Impact per Paper (SNIP) I 0.598 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      It Is the Time to Think About a Treat-to-Target Strategy for Knee Osteoarthritis

      article-commentary

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Osteoarthritis (OA) is a rheumatic disease that affects the well-being of the patient, compromises physical and mental function, and affects other quality of life aspects. In the literature, several evidence-based guidelines and recommendations for the management of knee osteoarthritis (KOA) are available. These recommendations list the different therapeutic options rather than addressing a hierarchy between the treatments and defining the real target. Therefore, a question arises: are patients and physicians satisfied with the current management of KOA? Actually, the answer may be negative, thus suggesting a change in our therapeutic strategies. In this article, we address this challenge by suggesting that it is time to develop a “treat to target strategy” for KOA.

          Most cited references10

          • Record: found
          • Abstract: found
          • Article: not found

          The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review.

          D. Pereira, B Peleteiro, J. Araujo … (2011)
          To understand the differences in prevalence and incidence estimates of osteoarthritis (OA), according to case definition, in knee, hip and hand joints. A systematic review was carried out in PUBMED and SCOPUS databases comprising the date of publication period from January 1995 to February 2011. We attempted to summarise data on the incidence and prevalence of OA according to different methods of assessment: self-reported, radiographic and symptomatic OA (clinical plus radiographic). Prevalence estimates were combined through meta-analysis and between-study heterogeneity was quantified. Seventy-two papers were reviewed (nine on incidence and 63 on prevalence). Higher OA prevalences are seen when radiographic OA definition was used for all age groups. Prevalence meta-analysis showed high heterogeneity between studies even in each specific joint and using the same OA definition. Although the knee is the most studied joint, the highest OA prevalence estimates were found in hand joints. OA of the knee tends to be more prevalent in women than in men independently of the OA definition used, but no gender differences were found in hip and hand OA. Insufficient data for incidence studies didn't allow us to make any comparison according to joint site or OA definition. Radiographic case definition of OA presented the highest prevalences. Within each joint site, self-reported and symptomatic OA definitions appear to present similar estimates. The high heterogeneity found in the studies limited further conclusions. Copyright © 2011 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
          Article 0 comments Cited 253 times – based on 0 reviews     Review now
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).

            Olivier Bruyère, Cyrus Cooper, Jean-Pierre Pelletier … (2014)
            Existing practice guidelines for osteoarthritis (OA) analyze the evidence behind each proposed treatment but do not prioritize the interventions in a given sequence. The objective was to develop a treatment algorithm recommendation that is easier to interpret for the prescribing physician based on the available evidence and that is applicable in Europe and internationally. The knee was used as the model OA joint.
            Article 0 comments Cited 137 times – based on 0 reviews     Review now
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: Results from a prospective multinational study.

              N Bellamy, Maria Cepero, Robrecht van der Wel … (2012)
              To estimate the minimum clinically important improvement (MCII) and patient acceptable symptom state (PASS) values for 4 generic outcomes in 5 rheumatic diseases and 7 countries. We conducted a multinational (Australia, France, Italy, Lebanon, Morocco, Spain, and The Netherlands) 4-week cohort study involving 1,532 patients who were prescribed nonsteroidal antiinflammatory drugs for ankylosing spondylitis, chronic back pain, hand osteoarthritis, hip and/or knee osteoarthritis, or rheumatoid arthritis. The MCII and PASS values were estimated with the 75th percentile approach for 4 generic outcomes: pain, patient global assessment, functional disability, and physician global assessment, all normalized to a 0-100 score. For the whole sample, the estimated MCII values for absolute change at 4 weeks were -17 (95% confidence interval [95% CI] -18, -15) for pain; -15 (95% CI -16, -14) for patient global assessment; -12 (95% CI -13, -11) for functional disability assessment; and -14 (95% CI -15, -14) for physician global assessment. For the whole sample, the estimated PASS values were 42 (95% CI 40, 44) for pain; 43 (95% CI 41, 45) for patient global assessment; 43 (95% CI 41, 44) for functional disability assessment; and 39 (95% CI 37, 40) for physician global assessment. Estimates were consistent across diseases and countries (for subgroups ≥20 patients). This work allows for promoting the use of values of MCII (15 of 100 for absolute improvement, 20% for relative improvement) and PASS (40 of 100) in reporting the results of trials of any of the 5 involved rheumatic diseases with pain, patient global assessment, physical function, or physician global assessment used as outcome criteria. Copyright © 2012 by the American College of Rheumatology.
              Article 0 comments Cited 133 times – based on 0 reviews     Review now
                Bookmark
                All references

                Author and article information

                Journal
                Journal ID (nlm-ta): Ther Clin Risk Manag
                Journal ID (iso-abbrev): Ther Clin Risk Manag
                Journal ID (publisher-id): TCRM
                Journal ID (pmc): tcriskman
                Title: Therapeutics and Clinical Risk Management
                Publisher: Dove
                ISSN (Print): 1176-6336
                ISSN (Electronic): 1178-203X
                Publication date (Electronic): 23 December 2019
                Publication date Collection: 2019
                Volume: 15
                Pages: 1479-1482
                Affiliations
                [1 ]Rheumatology Unit, San Pietro Fatebenefratelli Hospital , Rome, Italy
                [2 ]Department of Family Medicine, School of Kinesiology Western University, Western Centre for Public Health & Family , London, Ontario, Canada
                [3 ]Center for Treatment Comparison and Integrative Analysis Division of Rheumatology, Tufts Medical Center , Boston, MA, USA
                [4 ]Department of Rheumatology, Hôpital Henri Mondor , Creteil, France
                [5 ]Rheumatology Department, AP-HP, Saint-Antoine Hospital , Paris, France
                [6 ]Academic Department of Orthopaedics, Hull and East Yorkshire NHS Trust, Castle Hill Hospital , Cottingham, UK
                [7 ]Joint and Bone Research Unit, IIS-Fundacion Jimenez Diaz UAM , Madrid, Spain
                [8 ]Division of Rheumatology and Clinical Immunology, Humanitas Research Hospital , Rozzano, Milan, Italy
                [9 ]Division of Rheumatology AOUC, Department of Experimental and Clinical Medicine, University of Florence , Florence, Italy
                Author notes
                Correspondence: N Isailovic Division of Rheumatology and Clinical Immunology, Humanitas Research Hospital , Via A. Manzoni 56, Rozzano20089, Milan, ItalyTel +39-02-8224-5118 Email natasa.isailovic@humanitasresearch.it
                Author information
                https://orcid.org/http://orcid.org/0000-0002-3397-6478
                https://orcid.org/http://orcid.org/0000-0002-8069-5783
                https://orcid.org/http://orcid.org/0000-0002-9161-4731
                https://orcid.org/http://orcid.org/0000-0002-3241-991X
                Article
                Publisher ID: 221562
                DOI: 10.2147/TCRM.S221562
                PMC ID: 6935020
                SO-VID: bf3dd971-9a2f-4e69-9334-e01dba5a7d23
                Copyright statement: © 2019 Migliore et al.
                License:

                This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.php).

                History
                Date received : 02 July 2019
                Date accepted : 04 November 2019
                Page count
                References: 17, Pages: 4
                Categories
                Subject: Expert Opinion

                ScienceOpen disciplines: Medicine
                Keywords: osteoarthritis,knee osteoarthritis,treat to target
                Data availability:
                ScienceOpen disciplines: Medicine
                Keywords: osteoarthritis, knee osteoarthritis, treat to target

                Comments

                Comment on this article